In a November 22nd release, Hendrix Genetics announced that Paine Schwartz Partners has acquired fifty percent of the equity of Hendrix Genetics.  The remaining shareholding will be held by Thijs Hendrix and Antoon van den Berg who will continue as partners with the U.S. investor.  NPM a shareholder since 2015 will divest their minority interest.

Hendrix Genetics was founded in 2005 and is headquartered in Boxmeer, the Netherlands.  The company operates breeding programs in turkeys, egg production, swine, salmon, trout and shrimp under 15 brands.  Egg production breeds include ISA, DeKalb, Bovans, Shaver, Babcock with traditional strains marketed as SASSO . Turkeys are bred and distributed under the Hybrid brand.  Hendrix Genetics operates in 25 nations and employs 3,500.

The management team will continue to be led by Jolanda van Haarlem, the CEO with the support of the co-founders and the Supervisory Board.  Thijs Hendrix noted, “We are excited to partner with the Paine Schwartz team to build on our strong foundation and further grow by continuing to develop innovative solutions for the animal protein sector that meet the challenges of food production.”  He added, “This new investment from Paine Schwartz will help us to further accelerate growth through expansion into new markets and sustain our leadership in technology and R & D.

Kevin Schwartz, CEO of Paine Schwartz stated, “This strategic investment in Hendrix Genetics is directly aligned with our long-term thesis of identifying companies that sustainably increase productivity in the production of agriculture commodities required to feed an ever-growing global population.”